Cellebrite DI Ltd.

NASDAQ:CLBT

Software - Infrastructure

Technology
$11.16 -0.40%

-$0.05 today

Market cap
$2.80B
Beta
1.17
P/E (TTM)
42.6
EPS (TTM)
$0.29
52W Low $11.02High $19.98

Volume 2.36M

Average 2.08M

CLBT Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Cellebrite DI Ltd.NASDAQ: CLBT

Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026

Cash & equivalents falls 20.7% from a year ago

Cash & equivalents stood at $223.06M at the end of Q3 FY2026, down 20.7% from a year earlier and up 57.9% from the prior quarter. Over 3 fiscal years it compounded at +12.4% a year.

Context

  • Cash & equivalents amounted to 20.9% of total assets at the end of Q3 FY2026, down 12.8 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -20.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$223.06M+57.9% QoQ
Last fiscal yearDec 2025
$124.46M-35.1% YoY
Year agoSep 2025
$281.36M-20.7% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.7%——
1 year-35.1%——
3-year CAGR+12.4%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
124.46M USD
Year-over-year change
-35.1%
4-year CAGR
-3.9%

Cash & Equivalents vs competitors

How CLBT compares with its peers on the latest reported figures

  • CLBT's Sep 2026 cash & equivalents of $223.06M is the 2nd highest of the 4 companies compared; the peer median is $14.24M.
  • Its year-over-year change of -20.7% is the 3rd highest of 4, against a peer median of +2.5%.
  • Cash & equivalents amounts to 20.9% of total assets for CLBT, versus a peer median of 15.6%.
CLBT Competitors Peer median
Cash & Equivalents for CLBT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AXONAxon Enterprise, Inc.Sep 2026$1.46B +2.5%+50.3%16.5%
CLBTCellebrite DI Ltd.Sep 2026$223.06M -20.7%+12.4%20.9%
SSTISoundThinking, Inc.Mar 2026$14.24M +22.2%+14.7%11.3%
SPCBSuperCom Ltd.Mar 2026$11.07M -35.4%+34.7%15.6%
Peer median (excluding CLBT) $14.24M+2.5%+34.7%15.6%

Competitors are the stored peer set for CLBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents145.97M87.65M189.52M191.66M124.46M
Short-term Investments35.59M95.98M113.41M255.56M312.59M
Net Receivables67.51M78.76M77.27M82.36M104.97M
Inventory6.51M10.18M9.94M8.94M7.6M
Other Current Assets7.88M14.77M23.06M18.18M6.6M
Total Current Assets273.21M295.93M422.08M567.59M575.85M
Property, Plant & Equipment (Net)16.76M32.91M30.16M27.6M38.52M
Goodwill26.83M26.83M26.83M28.71M119.56M
Intangible Assets11.23M11.25M10.59M11.31M81.47M
Long-term Investments022.13M28.86M36.6M97.96M
Tax Assets9.8M12.51M14.54M11.07M10.88M
Other Non-current Assets1.96M1.73M12.89M7.68M14.62M
Total Non-current Assets66.57M107.36M123.87M122.97M363M
Total Assets339.78M403.29M532.89M690.57M938.85M
Account Payables9.55M4.61M8.28M11.08M16.83M
Short-term Debt00000
Tax Payables8.24M2.85M833K756K0
Deferred Revenue123.68M153.34M196.59M217.64M278.24M
Other Current Liabilities009.04M00
Total Current Liabilities186.57M207.78M253.82M295.5M369.66M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)36.43M42.17M47.1M45.25M49.53M
Other Non-current Liabilities190.13M69.13M188.59M6.95M16.68M
Total Non-current Liabilities226.56M121.65M244.85M59.05M84.88M
Total Liabilities413.13M329.43M498.67M354.55M454.53M
Common Stock00000
Retained Earnings78.44M199.24M118.14M(164.86M)(86.54M)
Accumulated OCI1.37M331K1.05M2.09M2.22M
Other Stockholders Equity00000
Minority Interest00000
Total Equity(73.35M)73.87M34.21M336.02M484.32M
Total Debt015.36M14.13M10.97M22.67M
Net Debt(145.97M)(72.29M)(175.39M)(180.69M)(101.79M)

Cellebrite DI Ltd.

NASDAQ:CLBT

Intrinsic Alpha fair value

Locked

Current Price

$11.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.